{COPYRIGHT NASAL INHALATION A NEW HOPE FOR DEPRESSION IN EUROPEAN COUNTRIES ?

The emergence of esketamine delivery system represents a groundbreaking advancement in the treatment of treatment-resistant mood disorders across European nations . While until recently requiring in-clinic administration, this option allows for a greater scope of patient accessibility , although